Tesamorelin

CAS No.: 218949-48-5

Tesamorelin Chemical Structure

Molecular formula: C₂₂₁H₃₆₆N₇₂O₆₇S

Molecular weight: 5134. 7233

Patent period: —

Dositive specifications: 2 mg BASE/VIAL

Injection : 2 mg /once day

Oral tablets: —

Injection: —

Get in touch Download

Products are for laboratory research use only. Not for human use. We do not sell to patients.

Biological Activity

EGRIFTA is a growth hormone releasing factor (GRF) analogindicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy:

__ EGRIFTA

Chemical Properties

ACTIONS	—
CAS NO.	218949-48-5
FORMULA	C₂₂₁H₃₆₆N₇₂O₆₇S
M. WT	5134. 7233
PURITY	—
SYNONYMS	TesamorelinAcetate Tesamorelin (usan) USP/EP/BP D06655 Tesamorelin (usan)
STORAGE	—

Online Inquiry

Obesity

The number of global obesity in 2020 reached 1.211 billion, an increase of 58 million people from 2019, an increase of 5.04% year -on -year.In 2020, the number of obesity in China reached 220 million people, an increase of 1.10 billion from 2019, an increase of 4.77%year -on -year.

Other Drug Peptide More+

Linaclotide new

Linaclotide is a potent and selective guanylate cyclase C agonist; Developed for the treatment of constipation-type irritable bowel syndrome (IBS-C) and chronic constipation.
Thymalfasin

Thymalfasin is a chemically synthesized version of thymosin alpha 1 that is identical to human thymosin alpha 1. Thymosin alpha 1 is an acetylated polypeptide.

Product Catalog

Tesamorelin

GUIZHOU MTPEPTIDES BIOTECHNOLOGY CO., LTD